semaglutide plus tirzepatide TrimRX Semaglutide & Tirzepatide Weight Loss

Full disclaimer 1.Retatrutide (LY3437943) is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors, developed by Eli Lilly 2.Phase 2 trials demonstrated up to 24.2% body weight loss at 48 weeksthe highest weight loss ever reported in a Phase 2 obesity trial 3.Triple mechanism activates multiple metabolic pathways: appetite suppression (GLP-1), improved insulin sensitivity (GIP), and increased energy expenditure (glucagon) 4.Currently in Phase 3 TRIUMPH trials for weight management, type 2 diabetes, NASH, and osteoarthritis

In clinical trials, semaglutide at 0.4 mg daily led to an average 13% reduction in body weight

Love that B12 is included

You're not white-knuckling through hungeryou genuinely feel satisfied with less food

Fill out the form to explore personalized hormone and weight loss treatment Rejuvime Medical Look better, feel stronger, and live with renewed confidence